Recently, the expression of HER2, EGFR1, VEGFR-2, PDGFR-β, c-KIT, and ERK1/ERK2 has been investigated in various canine tumors, with mesenchymal tumors showing the lowest expression levels and carcinomas showing the highest expression levels. Here, MAPK1 is linked to mesenchymal cell neoplasm.